about
Who wants to join preventive trials?--Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]Epidemiological data sources in Estonia: a survey of registries and databases.Testicular cancer incidence in eight northern European countries: secular and recent trends.Associations between aspirin use and aging macula disorder: the European Eye Study.Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration.Cancer epidemiology in the former Soviet Union.Childhood leukaemia in Europe after Chernobyl: 5 year follow-upThe Estonian study of Chernobyl cleanup workers: I. Design and questionnaire data.Use of mammography and Pap smear in Estonia, a country without organized cancer screening.Novel quantitative pigmentation phenotyping enhances genetic association, epistasis, and prediction of human eye colour.Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study.Mediterranean Diet Score and Its Association with Age-Related Macular Degeneration: The European Eye Study.Association Between Myopia, Ultraviolet B Radiation Exposure, Serum Vitamin D Concentrations, and Genetic Polymorphisms in Vitamin D Metabolic Pathways in a Multicountry European Study.Associations between Serum Vitamin D and Genetic Variants in Vitamin D Pathways and Age-Related Macular Degeneration in the European Eye Study.Recent changes in breast cancer incidence and mortality in Estonia: Transition to the west.Contraceptive use among young women in Estonia: Association with contraceptive services.HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757].Visual impairment and quality of life in the older European population, the EUREYE study.Population health and status of epidemiology: WHO European Region I.Risk factors for pulmonary tuberculosis in Estonia.Mortality of childhood-onset IDDM patients in Estonia.Use of mammography, Pap test and prostate examination by body mass index during the developmental period of cancer screening in Estonia.Impact of rapid socio-economic changes on teenage pregnancies in Estonia during 1992-2001.A comparative study of cancer registries in the German Democratic Republic and the Estonian SSR.Time trends in cancer incidence in the German Democratic Republic 1968-1981.Randomized trial with fruits and vegetables in prevention of cancer.Bladder cancer in Estonia, 1968-1992: incidence, mortality, prevalence and survival.Factors associated with serum/plasma concentrations of vitamins A, C, E and carotenoids in older people throughout Europe: the EUREYE study.Biodosimetry of Chernobyl cleanup workers from Estonia and Latvia using the glycophorin A in vivo somatic cell mutation assay.Population density and childhood leukaemia: results of the EUROCLUS studyHarmonization may be counterproductive--at least for parts of Europe where public health research operates effectivelyEpidemiological research labelled as a violation of privacy: the case of EstoniaEffect of Estonian law on prospects for public health researchFactors associated with serum 25-hydroxyvitamin D concentrations in older people in Europe: the EUREYE studyTesticular cancer in nine northern european countriesThyroid Nodularity and Cancer among Chernobyl Cleanup Workers from EstoniaSome epidemiological data on lung cancer in the USSRCancer survival in Estonia from 1978 to 1987On the background of differences in survival of female breast cancer patients in the German Democratic Republic and the Estonian SSR
P50
Q24799634-C6DFC17C-6BDB-476E-A415-E5167DD2FEE6Q30623715-231FC793-50CF-4185-81B4-35DB5620046AQ33983798-BC918BCE-5203-4801-9DF6-C042DC2245DFQ34028568-02A32C6B-99B0-4942-9620-9CD7D4D83A66Q34805968-7CFF0E73-2292-409D-B2BE-891537C9CB6AQ35360842-8270BCBF-966B-4D06-A204-3A1A241D4199Q36138659-6AE53AB1-D25D-4834-AB7D-720B383DC801Q36860096-54D8BD3D-E924-4B1E-957C-24AE4FCF64DEQ37243847-CC1A8D9E-F203-42BA-A89A-7CBC45AD8843Q37667864-426CFB7D-1DDE-422E-95E4-5DC751AC3825Q38883806-25A2C898-DB53-4606-AE57-7AF536AF0F94Q39071763-68A97D81-84DA-4A3B-A29B-595193BC9B44Q39130068-892860B0-0859-4C11-AF30-69A4FC9AD015Q39234985-BD7A811B-D3F7-4D1F-B865-EB2FD1618A16Q39738224-BF047596-01FF-422A-8C79-4B7C942232F9Q40812177-2384FA9B-6CE1-4B27-83DB-F3EAA8A1CC8BQ42618823-62F19240-EC16-4BFC-9038-F1F07D5954B1Q42663874-C5F1D002-2935-4A35-8849-504996FB5976Q43690220-EE482354-DA8F-401C-96E4-2FC3813F9D69Q43883904-4A496019-AD8D-41ED-A620-6EB156EF0E53Q44168923-0BFC08BA-72D3-4AEA-865A-F7999E49ECB4Q44491617-8A5BF8F3-D6DA-4B94-83CC-A2B24315EA5BQ44920738-A28B881C-84B7-4B7B-A9A7-5FBF98C9048BQ47279680-7B8C4FC8-E4B7-4C46-872D-8F586E2986A4Q48664141-50B19731-CCE3-4527-8117-6D51DDA0CC18Q50575260-B0A2CEC4-0F6A-4F17-A72E-662557F6A825Q50723597-5924E757-9D19-40CE-9FF0-61A434976DDEQ50936128-F50C28D0-B567-463D-8669-610791261A31Q51349877-AD0FFC8B-CCCC-4601-B42B-E1EA25087E26Q53446486-BA757565-BECA-4651-B6A9-666A30C012ACQ56995048-2E8E9458-CEF0-4629-BBD6-678A65456D51Q57543425-AAA5F891-22F8-4153-A10D-D428D7F849D8Q57764679-55606013-F978-4D48-8E72-CA8F83F6F8C1Q57766369-AEAF4D8A-8835-4736-A34D-858614E073D1Q58113857-4E48EF36-AA6F-47A4-945E-3C21A385CA1DQ58411745-147A3975-0700-4A90-A25C-A982C21D5B3FQ59831060-6D7B68B2-5056-4340-BEC8-E5A7E828BD95Q67586282-853DFCD2-639B-4667-841C-46559BFD7107Q68003756-AF9DABA9-C76F-49C4-AF5B-4024AD4240AEQ68593662-B09F5C87-6C17-42D1-8894-2FADF95225EE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mati Rahu
@ast
Mati Rahu
@en
Mati Rahu
@es
Mati Rahu
@nl
type
label
Mati Rahu
@ast
Mati Rahu
@en
Mati Rahu
@es
Mati Rahu
@nl
prefLabel
Mati Rahu
@ast
Mati Rahu
@en
Mati Rahu
@es
Mati Rahu
@nl
P106
P31
P496
0000-0001-7172-8048